Ongoing Clinical Trials | Zendy

Leopold Hentschel | Zendy; Anke Rentsch | Zendy; Felicitas Lenz | Zendy; Beate Hornemann | Zendy; Jochen Schmitt | Zendy; Michaël Baumann | Zendy; Gerhard Ehninger | Zendy; M. Schüler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ongoing Clinical Trials

Author(s) -

Leopold Hentschel,

Anke Rentsch,

Felicitas Lenz,

Beate Hornemann,

Jochen Schmitt,

Michaël Baumann,

Gerhard Ehninger,

M. Schüler

Publication year - 2016

Publication title -

oncology research and treatment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.553

H-Index - 48

eISSN - 2296-5262

pISSN - 2296-5270

DOI - 10.1159/000445517

Subject(s) - clinical trial , medicine , computer science

CAPP 2 Randomized controlled trial of colorectal polyp and cancer prevention using aspirin and resistant starch in carriers of hereditary nonpoly-posis colon cancer (HNPCC) Prof. John Burn University of Newcastle, UK Phase II, multicenter (33 centers), prospective, double-blind trial Factorial design Regimen: Aspirin 600 mg, resistant starch 30 g for 2-4 years Control: Placebo/active Endpoint: Colorectal neoplasm Patient population: Gene carriers of hereditary HNPCC n=1000 Ongoing (start January 1999; end December 2006) MRC, Cancer Research UK, Bayer AG, National Starch and Chemical Company Ms. Gail Barker Newcastle upon Tyne, UK

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research